The US Trade Representative’s Office says it will exclude 12 medtech products from a long list of items imported from China that are slated to be slapped with a 25% tariff.
The 9 July decision from the USTR comes on the heels of testimony by device industry advocacy group AdvaMed in...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?